Principal Investigator
Simone Marnitz, Prof.
Department of Radiation Oncology, University Hospital of Cologne
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
DRUG(2)
PROCEDURE(1)
Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
1 trial
phase_2
universitätsklinikum-kölnConcurrent Chemo-radio-immunotherapy (Nivolumab/Ipilimumab)
1 trial
phase_2
universitätsklinikum-kölnMaintenance Treatment (Nivolumab/Ipilimumab)
1 trial
phase_2
universitätsklinikum-köln3 unique interventions2 categories
Analytics
Trial Phases
Phase 21
Trial Status
Other1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients
Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
Principalinvestigator
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Department of Radiation Oncology, University Hospital of Cologne
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Similar investigators will appear here based on research areas and collaboration patterns.
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients
Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
All 1 trials loaded